GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (NAS:IRTC) » Definitions » Piotroski F-Score

IRTC (iRhythm Technologies) Piotroski F-Score : 5 (As of Jun. 29, 2025)


View and export this data going back to 2016. Start your Free Trial

What is iRhythm Technologies Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

iRhythm Technologies has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for iRhythm Technologies's Piotroski F-Score or its related term are showing as below:

IRTC' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 6
Current: 5

During the past 11 years, the highest Piotroski F-Score of iRhythm Technologies was 6. The lowest was 1. And the median was 4.


iRhythm Technologies Piotroski F-Score Historical Data

The historical data trend for iRhythm Technologies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies Piotroski F-Score Chart

iRhythm Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 2.00 3.00 3.00 6.00

iRhythm Technologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 3.00 6.00 5.00

Competitive Comparison of iRhythm Technologies's Piotroski F-Score

For the Medical Devices subindustry, iRhythm Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRhythm Technologies's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where iRhythm Technologies's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Net Income was -20.107 + -46.182 + -1.333 + -30.7 = $-98.3 Mil.
Cash Flow from Operations was 11.84 + 24.347 + 19.232 + -7.891 = $47.5 Mil.
Revenue was 148.047 + 147.538 + 164.325 + 158.677 = $618.6 Mil.
Gross Profit was 103.471 + 101.476 + 115.068 + 109.216 = $429.2 Mil.
Average Total Assets from the begining of this year (Mar24)
to the end of this year (Mar25) was
(909.755 + 919.185 + 909.688 + 931.449 + 926.098) / 5 = $919.235 Mil.
Total Assets at the begining of this year (Mar24) was $909.8 Mil.
Long-Term Debt & Capital Lease Obligation was $719.4 Mil.
Total Current Assets was $636.0 Mil.
Total Current Liabilities was $111.3 Mil.
Net Income was -18.482 + -27.116 + -38.699 + -45.667 = $-130.0 Mil.

Revenue was 124.13 + 124.604 + 132.511 + 131.929 = $513.2 Mil.
Gross Profit was 86.225 + 82.474 + 87.426 + 87.516 = $343.6 Mil.
Average Total Assets from the begining of last year (Mar23)
to the end of last year (Mar24) was
(421.701 + 429.488 + 439.769 + 433.144 + 909.755) / 5 = $526.7714 Mil.
Total Assets at the begining of last year (Mar23) was $421.7 Mil.
Long-Term Debt & Capital Lease Obligation was $721.7 Mil.
Total Current Assets was $687.5 Mil.
Total Current Liabilities was $96.8 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

iRhythm Technologies's current Net Income (TTM) was -98.3. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

iRhythm Technologies's current Cash Flow from Operations (TTM) was 47.5. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar24)
=-98.322/909.755
=-0.10807525

ROA (Last Year)=Net Income/Total Assets (Mar23)
=-129.964/421.701
=-0.30818993

iRhythm Technologies's return on assets of this year was -0.10807525. iRhythm Technologies's return on assets of last year was -0.30818993. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

iRhythm Technologies's current Net Income (TTM) was -98.3. iRhythm Technologies's current Cash Flow from Operations (TTM) was 47.5. ==> 47.5 > -98.3 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=719.362/919.235
=0.78256594

Gearing (Last Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=721.716/526.7714
=1.37007438

iRhythm Technologies's gearing of this year was 0.78256594. iRhythm Technologies's gearing of last year was 1.37007438. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar25)=Total Current Assets/Total Current Liabilities
=636.013/111.344
=5.71214435

Current Ratio (Last Year: Mar24)=Total Current Assets/Total Current Liabilities
=687.455/96.841
=7.09880113

iRhythm Technologies's current ratio of this year was 5.71214435. iRhythm Technologies's current ratio of last year was 7.09880113. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

iRhythm Technologies's number of shares in issue this year was 31.59. iRhythm Technologies's number of shares in issue last year was 31.033. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=429.231/618.587
=0.69388946

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=343.641/513.174
=0.66963837

iRhythm Technologies's gross margin of this year was 0.69388946. iRhythm Technologies's gross margin of last year was 0.66963837. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar24)
=618.587/909.755
=0.679949

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar23)
=513.174/421.701
=1.21691435

iRhythm Technologies's asset turnover of this year was 0.679949. iRhythm Technologies's asset turnover of last year was 1.21691435. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+1+1+1+0+0+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

iRhythm Technologies has an F-score of 5 indicating the company's financial situation is typical for a stable company.

iRhythm Technologies  (NAS:IRTC) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


iRhythm Technologies Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of iRhythm Technologies's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


iRhythm Technologies Business Description

Traded in Other Exchanges
Address
699 8th Street, Suite 600, San Francisco, CA, USA, 94103
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Executives
Daniel G. Wilson officer: EVP, Strategy Corp Dev Inv Rel 699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103
Chad Patterson officer: Chief Commercial Officer 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Minang Turakhia officer: EVP, CMO & CSO C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Quentin S. Blackford director, officer: President and CEO 7475 LUSK BLVD., SAN DIEGO CA 92121
Patrick Michael Murphy officer: CLO & EVP RA/QA MrktAcs & Gov 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Sumi Shrishrimal officer: EVP, Chief Risk Officer 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Abhijit Y Talwalkar director ONE AMD PLACE, PO BOX 3453, SUNNYVALE CA 94088
Brice Bobzien officer: Chief Financial Officer C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Mervin Smith officer: EVP Strategic Business Ops C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Marc W. Rosenbaum officer: Chief Accounting Officer 7475 LUSK BLVD., SAN DIEGO CA 92121
Mark J. Day officer: EVP, Research & Development C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 500, SAN FRANCISCO CA 94103
Brian B Yoor director 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064
Mojdeh Poul director 3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST PAUL MN 55144-1000
Douglas Devine officer: Chief Financial Officer C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103
Bairey Merz Cathleen Noel director 16664 CUMBRE VERDE COURT, PACIFIC PALISADES CA 90272